Bisoprolol

CHEMBL645 Phase 4 Onaylandı Small molecule

Half-Life

10-12 hours

Bioavailability

—

Protein Binding

—

Molecular Weight

325.4 g/mol

LogP

1.9

Phase

4

A selective beta-1 adrenergic blocker used to treat high blood pressure, heart failure, and certain abnormal heart rhythms. By reducing the heart's workload and slowing the heart rate, it helps protect the heart over time. It is preferred over non-selective beta-blockers in patients with mild respiratory conditions.

Moleküler Ağırlık

325,4470 g/mol

LogP

1,90

TPSA

60,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Cardiovascular Disease Chronic Obstructive Pulmonary Disease Chronic Kidney Disease Lymphoma Type 2 Diabetes Hypertension Breast Cancer Heart Failure Atrial Fibrillation Leukemia

İlaç Sınıfları

C — C - Cardiovascular System

Etki Mekanizması

Highly selective beta-1 adrenergic receptor blocker reducing heart rate and myocardial contractility.

Pharmacokinetics (PK)

Half-Life 10-12 hours

Pharmacodynamics (PD)

Mekanizma

Highly selective beta-1 adrenergic receptor blocker reducing heart rate and myocardial contractility.

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1

InChI

InChI=1S/C18H31NO4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4/h5-8,14-15,17,19-20H,9-13H2,1-4H3

Molecular Formula

C18H31NO4

HBD / HBA

2 / 5

Döndürülebilir Bağlar

12

Ağır Atomlar

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A selective beta-1 adrenergic blocker used to treat high blood pressure, heart failure, and certain abnormal heart rhythms. By reducing the heart's workload and slowing the heart rate, it helps protect the heart over time. It is preferred over non-selective beta-blockers in patients with mild respiratory conditions.

Highly selective beta-1 adrenergic receptor blocker reducing heart rate and myocardial contractility.

Key pharmacokinetic parameters for Bisoprolol: Half-life: 10-12 hours.

Yes, Bisoprolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

Same Drug Class

Atorvastatin Small molecule Amlodipine Small molecule Lisinopril Small molecule Metoprolol Small molecule

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL645. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 2405. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Bisoprolol PillFYI'da

Yapı

Hızlı Veriler

Class: C - Cardiovascular System
Formül: C18H31NO4
Eş Anlamlılar: 3

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.

Bisoprolol

Terapötik Alanlar

İlaç Sınıfları

Etki Mekanizması

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

Cite this structure

Embed this structure

No targets recorded

No interactions recorded

No side effects recorded

Sıkça Sorulan Sorular

Related Drugs

Same Drug Class

References & Data Sources

Embed This Widget